NVCR FY 2020 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

FY 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$494M+40.7% YoY

Gross Profit

$388M78.5% margin

Operating Income

$30M6.1% margin

Net Income

$20M4.0% margin

EPS (Diluted)

$0.18

Cash Flow

Operating Cash Flow

$99M

Free Cash Flow

$84M

Stock-Based Comp.

$76M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$575M

Stockholders' Equity

$477M

Cash & Equivalents

$246M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$494M	$351M	+40.7%
Gross Profit	$388M	$263M	+47.6%
Operating Income	$30M	-$914,000	+3426.1%
Net Income	$20M	-$7M	+374.0%